rt-01
Biologicalexperimental
Clinical trial activity
6 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2021 (NCT05136937)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05387226 | Phase 1 | May 31, 2022 | Bengbu Medical College |
| NCT05205408 | Phase 1 | Feb 24, 2022 | Bengbu Medical College |
| NCT05205421 | Phase 1 | Jan 18, 2022 | Bengbu Medical College |
| NCT05228119 | Phase 1 | Jan 4, 2022 | Xuzhou Medical University |
| NCT05122572 | Phase 1 | Nov 1, 2021 | Wuxi People's Hospital |
| NCT05136937 | Phase 1 | Nov 1, 2021 | Wuxi People's Hospital |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bengbu Medical College | Academic/Hospital | 3 | 3 | 1 | 2022 |
| Wuxi People's Hospital | Academic/Hospital | 2 | 2 | 1 | 2021 |
| Xuzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1